Real-world study examines quality of life and compliance in young breast cancer patients on hormone-blocking therapy
NCT ID NCT05122377
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved 562 premenopausal women in China with hormone receptor-positive breast cancer who received a GnRHa injection to suppress ovarian function after surgery. Researchers measured their quality of life and how well they followed the treatment plan using questionnaires. The goal was to understand patient experiences and adherence in a real-world setting, without testing a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?